Posted inClinical Updates Hematology-Oncology Oncology
Circulating Tumor DNA in Large B-cell Lymphoma: Bridging Molecular Detection and Clinical Practice
Circulating tumor DNA (ctDNA) is emerging as a sensitive biomarker for measurable residual disease in large B-cell lymphoma, promising enhanced response assessment beyond PET imaging, but requires further validation for routine clinical integration.
